mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for EHMT1
Gene summary
Basic gene Info.Gene symbolEHMT1
Gene nameeuchromatic histone-lysine N-methyltransferase 1
SynonymsEUHMTASE1|Eu-HMTase1|FP13812|GLP|GLP1|KMT1D|bA188C12.1
CytomapUCSC genome browser: 9q34.3
Type of geneprotein-coding
RefGenesNM_001145527.1,
NM_024757.4,
DescriptionG9a-like protein 1H3-K9-HMTase 5histone H3-K9 methyltransferase 5histone-lysine N-methyltransferase EHMT1histone-lysine N-methyltransferase, H3 lysine-9 specific 5lysine N-methyltransferase 1D
Modification date20141219
dbXrefs MIM : 607001
HGNC : HGNC
Ensembl : ENSG00000181090
HPRD : 07383
Vega : OTTHUMG00000020995
ProteinUniProt: Q9H9B1
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_EHMT1
BioGPS: 79813
PathwayNCI Pathway Interaction Database: EHMT1
KEGG: EHMT1
REACTOME: EHMT1
Pathway Commons: EHMT1
ContextiHOP: EHMT1
ligand binding site mutation search in PubMed: EHMT1
UCL Cancer Institute: EHMT1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0016568chromatin modification12004135
GO:0016571histone methylation12004135
GO:0018027peptidyl-lysine dimethylation20118233


Top
Ligand binding site mutations for EHMT1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D1178D1178NCOAD1
C1062V1063ACOAD1
Y1173Y1173CCOAD1
Y1155E1154VCOAD1
F915G917CLUSC1
W1138V1140MSTAD1
F915A914VUCEC1
N936A934TUCEC1
D1171,E1169E1170DUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for EHMT1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C1062V1063A-1.6927401
E1169E1170D-1.4978539
D1171E1170D-1.4978539
D1178D1178N-1.4675492
Y1173Y1173C-1.3135736
N936A934T-0.91383454
Y1155E1154V-0.82805077
F915A914V-0.58081429
W1138V1140M-0.45412568
F915G917C-0.44169811
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for EHMT1 from PDB

Top
Differential gene expression and gene-gene network for EHMT1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of EHMT1 and the right PPI network was created from samples without mutations in the LBS of EHMT1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for EHMT1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0795833Kleefstra Syndrome8Biomarker, GeneticVariation
umls:C0025149Medulloblastoma1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for EHMT1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of EHMT1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of EHMT1
Multiple alignments for Q9H9B1 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas